MedicaidPrior AuthMedium impact
Izervay™ (avacincaptad pegol) (New)
Humana·IN · Ophthalmology·Medicaid
Effective date
Feb 1, 2026
We identified it
Jun 24, 2026
Summary
Humana is adding prior authorization requirements for Izervay (avacincaptad pegol), a new intravitreal injection for geographic atrophy secondary to age-related macular degeneration. This medication requires prescribing by an ophthalmologist or retinal specialist and has specific diagnostic criteria for approval.
Action Required
Before February 1, 2026: Ophthalmology practices must obtain prior authorization for Izervay (avacincaptad pegol) prescriptions for Indiana Medicaid patients. Ensure prescribing physician is an ophthalmologist or retinal specialist and patient has confirmed diagnosis of geographic atrophy secondary to AMD. Visit www.humana.com/PAL for medical and procedural coding information. Claims will be denied without proper prior authorization.